Andrew Jack

15.3k total citations · 4 hit papers
206 papers, 9.9k citations indexed

About

Andrew Jack is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, Andrew Jack has authored 206 papers receiving a total of 9.9k indexed citations (citations by other indexed papers that have themselves been cited), including 127 papers in Pathology and Forensic Medicine, 60 papers in Genetics and 59 papers in Oncology. Recurrent topics in Andrew Jack's work include Lymphoma Diagnosis and Treatment (100 papers), Chronic Lymphocytic Leukemia Research (56 papers) and Viral-associated cancers and disorders (29 papers). Andrew Jack is often cited by papers focused on Lymphoma Diagnosis and Treatment (100 papers), Chronic Lymphocytic Leukemia Research (56 papers) and Viral-associated cancers and disorders (29 papers). Andrew Jack collaborates with scholars based in United Kingdom, Canada and United States. Andrew Jack's co-authors include Russell Patmore, Roger G. Owen, Sharon Barrans, Eve Roman, Gareth J. Morgan, Andy C. Rawstron, Debra Howell, Stephen J. Richards, Paul Evans and Peter Johnson and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Nucleic Acids Research.

In The Last Decade

Andrew Jack

195 papers receiving 9.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

2015 611 citations Umberto Vitolo, Andrew Jack et al. profile →
Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network

2011 486 citations A. G. Smith, Debra Howell et al. profile →
Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles

2013 357 citations David Cunningham, Andrew Jack et al. profile →
Lymphoma incidence, survival and prevalence 2004–2014: sub-type analyses from the UK’s Haematological Malignancy Research Network

2015 282 citations Simon Crouch, Dan Painter et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Andrew Jack	6.2k	3.8k	3.8k	1.7k	1.6k	206	9.9k
Michele Ghielmini	6.5k 1.0×	3.1k 0.8×	4.5k 1.2×	1.5k 0.8×	1.2k 0.7×	134	8.8k
David J. Inwards	4.4k 0.7×	2.1k 0.6×	3.8k 1.0×	1.7k 1.0×	1.0k 0.7×	265	8.0k
Paul J. Kurtin	5.1k 0.8×	2.8k 0.7×	3.6k 1.0×	2.2k 1.3×	1.4k 0.9×	235	11.4k
Michael Crump	5.6k 0.9×	2.4k 0.6×	5.3k 1.4×	1.2k 0.7×	1.5k 1.0×	310	9.8k
Jonathan W. Friedberg	9.1k 1.5×	3.8k 1.0×	6.5k 1.7×	1.9k 1.1×	2.4k 1.6×	393	12.7k
Izidore S. Lossos	5.8k 0.9×	2.5k 0.7×	4.3k 1.1×	2.8k 1.6×	1.4k 0.9×	353	10.8k
Josette Brière	10.0k 1.6×	3.3k 0.9×	7.4k 2.0×	2.4k 1.4×	2.8k 1.8×	190	13.6k
German Ott	8.7k 1.4×	4.0k 1.0×	6.2k 1.7×	2.0k 1.1×	1.5k 1.0×	336	12.9k
Won Seog Kim	7.1k 1.1×	1.8k 0.5×	6.3k 1.7×	3.0k 1.7×	1.4k 0.9×	462	10.8k
Ann S. LaCasce	5.0k 0.8×	2.3k 0.6×	3.5k 0.9×	1.2k 0.7×	1.6k 1.1×	208	7.7k

Countries citing papers authored by Andrew Jack

Since Specialization

Citations

This map shows the geographic impact of Andrew Jack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Jack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Jack more than expected).

Fields of papers citing papers by Andrew Jack

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Jack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Jack. The network helps show where Andrew Jack may publish in the future.

Co-authorship network of co-authors of Andrew Jack

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Jack. A scholar is included among the top collaborators of Andrew Jack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Jack. Andrew Jack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shakil, Husain, Armaan K. Malhotra, Jetan H. Badhiwala, et al.. (2024). Time to Surgery Following Complete Cervical Spinal Cord Injury: Evolution of Clinical Practice Patterns Over a Decade from 2010 to 2020 Across North American Trauma Centers. Journal of Neurotrauma. 42(3-4). 272–279.

Jack, Andrew, et al.. (2023). A metal selection and structural optimisation methodology for large-scale direct-drive wind turbine electrical generators. IET conference proceedings.. 2023(17). 80–87. 1 indexed citations

Glinski, Alexander von, Emre Yilmaz, Basem Ishak, et al.. (2020). The Modified Iliac Screw: An Anatomic Comparison and Technical Guide. World Neurosurgery. 136. e608–e613. 6 indexed citations

Jack, Andrew, et al.. (2020). Malignant triton tumor in the setting of segmental neurofibromatosis: A rare case report and review of the literature. SHILAP Revista de lepidopterología. 24. 101073–101073. 1 indexed citations

Glinski, Alexander von, Emre Yilmaz, Basem Ishak, et al.. (2019). Neurovascular Relations in Modified Iliac Screws and Traditional Iliac Screw: Anatomic Study. World Neurosurgery. 134. e93–e97. 5 indexed citations

Wilson, Mitchell P., Cian O′Kelly, Andrew Jack, & Jeremy Rempel. (2018). Utilizing preprocedural CT scans to identify patients at risk for suboptimal external ventricular drain placement with the freehand insertion technique. Journal of neurosurgery. 130(6). 1–7. 13 indexed citations

Jack, Andrew, et al.. (2015). Effects of Regular Coke and Coke Zero on Blood Glucose, Serum Lipid Profile and Activities of Serum Aminotransferases in Healthy Human Subjects. International Journal of Science and Research (IJSR). 4(11). 1516–1519. 1 indexed citations

Smith, A. G., Dan Painter, Debra Howell, et al.. (2014). Determinants of survival in patients with chronic myeloid leukaemia treated in the new era of oral therapy: findings from a UK population-based patient cohort. BMJ Open. 4(1). e004266–e004266. 42 indexed citations

Zucca, Emanuele, Annarita Conconi, Daniele Laszlò, et al.. (2013). Addition of Rituximab to Chlorambucil Produces Superior Event-Free Survival in the Treatment of Patients With Extranodal Marginal-Zone B-Cell Lymphoma: 5-Year Analysis of the IELSG-19 Randomized Study. Journal of Clinical Oncology. 31(5). 565–572. 148 indexed citations

10.

Elkins, Kristi, Bing Zheng, MaryAnn Go, et al.. (2012). FcRL5 as a Target of Antibody–Drug Conjugates for the Treatment of Multiple Myeloma. Molecular Cancer Therapeutics. 11(10). 2222–2232. 69 indexed citations

11.

Hoskin, Peter, Amy A. Kirkwood, Caroline Brammer, et al.. (2012). FoRT: A Phase 3 Multi-Center Prospective Randomized Trial of Low Dose Radiation Therapy for Follicular and Marginal Zone Lymphoma. International Journal of Radiation Oncology*Biology*Physics. 85(1). 22–22. 4 indexed citations

12.

Lowry, Lisa, Paul Smith, Wendi Qian, et al.. (2011). Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: A randomised phase III trial. Radiotherapy and Oncology. 100(1). 86–92. 247 indexed citations

13.

Jack, Andrew & Brent Burbridge. (2011). The Utilisation of Radiology for the Teaching of Anatomy in Canadian Medical Schools. Canadian Association of Radiologists Journal. 63(3). 160–164. 43 indexed citations

14.

Barrans, Sharon, Simon Crouch, Alex Smith, et al.. (2010). Rearrangement of MYC Is Associated With Poor Prognosis in Patients With Diffuse Large B-Cell Lymphoma Treated in the Era of Rituximab. Journal of Clinical Oncology. 28(20). 3360–3365. 402 indexed citations

15.

Hoskin, Peter, Lisa Lowry, Alan Horwich, et al.. (2009). Randomized Comparison of the Stanford V Regimen and ABVD in the Treatment of Advanced Hodgkin's Lymphoma: United Kingdom National Cancer Research Institute Lymphoma Group Study ISRCTN 64141244. Journal of Clinical Oncology. 27(32). 5390–5396. 124 indexed citations

16.

Jack, Andrew. (2005). Organisation of neoplastic haematopathology services: a UK perspective. Pathology. 37(6). 479–492. 5 indexed citations

17.

Jack, Andrew & Sharon Barrans. (2004). Recent advances in the understanding of aggressive B-cell lymphomas. Current Diagnostic Pathology. 10(5). 360–373. 3 indexed citations

18.

Marcus, Robert, Kevin Imrie, Andrew Belch, et al.. (2003). An international multi-centre, randomized, open-label, phase III trial comparing rituximab added to CVP chemotherapy to CVP chemotherapy alone in untreated stage III/IV follicular non-Hodgkins lymphoma.. Ghent University Academic Bibliography (Ghent University). 34 indexed citations

19.

Rollinson, Sara, Philippa L. Roddam, Eleanor V. Willett, et al.. (2001). NAT2 Acetylator Genotypes Confer No Effect on the Risk of Developing Adult Acute Leukemia. Cancer Epidemiology and Prevention Biomarkers. 10(5). 567–568. 1 indexed citations

20.

Child, J. A., Andrew Jack, & Gareth J. Morgan. (1998). The lymphoproliferative disorders : handbook of diagnosis, investigation and management. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact